Showing results (81-90 of 609) with videos related to

Sort By:
Pageof 61
Urology|January 30, 2004
Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancerGlenn M Cannon, Patrick C Walsh, Alan W Partin, et al.
Cancer|April 10, 2004
Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2bStephen J Freedland, Alan W Partin, Jonathan I Epstein, et al.
Reviews in Urology|September 21, 2006
Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI)Matthew B Gretzer, Alan W Partin, Daniel W Chan, et al.
BJU International|January 29, 2013
Multiple cores of Gleason score 6 correlate with favourable findings at radical prostatectomyCarla L Ellis, Patrick C Walsh, Alan W Partin, et al.
The Journal of Urology|September 8, 2005
The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomyStephen J Freedland, Leslie A Mangold, Patrick C Walsh, et al.
European Urology|August 11, 2023
How Well Do Artificial Intelligence Chatbots Respond to the Top Search Queries About Urological Malignancies?David Musheyev, Alexander Pan, Stacy Loeb, et al.
The Journal of Urology|August 13, 2015
Importance of Reporting the Gleason Score at the Positive Surgical Margin Site: Analysis of 4,082 Consecutive Radical Prostatectomy CasesMax Kates, Nikolai A Sopko, Misop Han, et al.
Urology|March 29, 2008
Does laterality of positive needle biopsy in clinical T2a patients with prostate cancer affect biochemical recurrence-free survival?Ina Wu, Matthew E Nielsen, Misop Han, et al.
BJU International|March 6, 2010
Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenariansPhillip M Pierorazio, Elizabeth Humphreys, Patrick C Walsh, et al.
Urology|October 18, 2002
Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screeningLars Ellison, Carol D Cheli, Steven Bright, et al.
Pageof 61